NEWS

PHARMA IN THE NEWS

President giving a speech during the donation of COVID19 Relief Drugs to FG
Image
A Responsible, Active and People Focused Healthcare Advocacy Organisation.

Developing people. Delivering results.

Niropharm member organizations believe in working to improve healthcare indices and take active practical steps to support and be corporately responsible for the health of the citizens in very direct and tangible ways. 

Market Size

NIROPHARM Market Size in Nigeria is $218m (source BMI monitor, 2006) and this is constantly growing due to the opportunities and market potentials.

Pharma Imports

Imports of Pharmaceutical products constitute 70% of the Nigerian Pharma industry.

Local Manufacture

Local Manufacture accounts for the remaining 30% of pharmaceuticals in the country

Information

NIROPHARM is dedicated to working to improve and enhance the quality of service to the Nation, public (local and international) Image, and the scope of the Nigerian Pharmaceutical Industry who face a number of challenges. 

Some of the challenges that NIROPHRM is set  to tackle with all the resources it has at its disposal include: High cost of funds, Poor infrastructure, Poor IPR protection, Chaotic drug distribution, Lack of data for planning, High level of Counterfeiting, Low capacity of Regulatory Agencies, Regulatory Agency, not computerized, Poor surveillance particularly at the land borders